اخبار

نظرسنجي

به نظر شما در گروه فارماسيوتيکس کدام آزمايشگاه از نظر وضعيت دستگاههاي موجود و نحوه همکاري کارشناس آزمايشگاه با دانشجو مناسب تر مي باشد؟

آزمايشگاه صنعتي 55.3%
آزمايشگاه توليدي 7.5%
آزمايشگاه اشکال دارويي 5.8%
آزمايشگاه سامانه هاي نوين دارورساني 20.6%
آزمايشگاه تخصصي داروسازي 10.8%


مشاهده نتايج

صفحات پر بازديد

دانشکده داروسازی مشهد ( 161110 )
آزمایشگاه شیمی داروئي ( 53176 )
آزمایشگاه شیمی عمومي و شيمي آلي ( 50425 )
گروه شیمی دارویی ( 14834 )
سنتز ترکيبات دارويی ( 13428 )
واحد تحصیلات تکمیلی ( 12460 )
چیدمان دروس رشته داروسازی ( 11550 )
معرفی دانشجویان برتر دانشکده داروسازی ( 10877 )
دکتر بی بی صديقه فضلی بزاز ( 8828 )
دكتر سيد عادل معلم ( 8827 )
بیوانفورماتیک ( 8785 )
ریاست دانشکده داروسازی دکتر محسن ايمن شهيدي ( 8553 )
دکتر فرزین هادیزاده ( 8462 )
دكتر محمد رمضاني ( 8173 )
دکتر محمدرضا صابری ( 8155 )
همایشها و سمینارهای سال 1388 ( 8107 )
سیستم های دارورسانی نوین ( 7969 )
دكتر جواد بهروان ( 7618 )
گروه فارماسيوتيکس ( 7445 )
آزمایشگاه آنالیز دستگاه و عكس ( 7166 )
دكتر حسين حسين زاده ( 7054 )
دکتر اميد رجبي- گروه شيمي دارويي ( 7041 )
معاونت آموزشي ( 6827 )
گروه فارماكودينامي و سم شناسي ( 6807 )
گروه فارماكوگنوزي ( 6709 )

 دکتر محمودرضا جعفري > فعاليتهاي تحقيقاتي >  و) ارائه مقاله دركنگره ها يا سمينارهاي خارجي

 

فعاليتهاي پژوهشي
 
و) ارائه مقاله دركنگره ها يا سمينارهاي خارجي:
 
1) Foldvari, M. and Jaafari, M.R. 1994. Effect of synthetic P0-oligopeptides on the cell adhesion properties of P0 protein reconstituted into liposomes. Pharmaceutical Research, 11(10) S-328 (Congress of American Association of Pharmaceutical Sciences, SanDiego, USA, November 6-10, 1994) (Poster Presentation).

2) Jaafari, M.R. and Foldvari, M. 1997. Adhesive properties of P0 protein reconstituted into liposomes with different human melanoma cell lines. Pharmaceutical Research, 14(11) S-157 (Congress of American Association of Pharmaceutical Sciences, Boston, USA, November 2-6, 1997) (Poster Presentation).

3) Jaafari, M.R. and Foldvari, M. 1997. Inhibition of adherence of jurkat T cells to keratinocytes by LFA-1 derived and RGD peptides. Pharmaceutical Research, 14(11) S-312 (Congress of American Association of Pharmaceutical Sciences, Boston, USA, November 2-6, 1997) (Poster Presentation).

4) Jafari, M.R. and Foldvari, M. 1998. Liposome targeting to melanoma cells through adhesive peptides from immunoglobulin (Ig) domains. Pharmaceutical Research, 15(11) Supplement (Congress of American Association of Pharmaceutical Sciences, San Francisco, USA, November 15-19, 1998) (Poster Presentation).

5) Foldvari, M. andJaafari, M.R. 1997. Studies of adhesive properties of myelin P0 protein derived peptides. In: Juurlink, B.H.J., Devon, R.M., Doucette, J.R., Nazarali, A.J Cell Biology and Pathology of Myelin : Evolving Biological Concepts and Therapeutic Approaches (Altschul Symposia Series: Cell Biology and Pathology of Myelin : Evolving Biological Concepts and Therapeutic Approaches, Saskatoon, Canada June 27-29, 1996) (Poster Presentation).

6) Jaafari M.R., Khamesipour A., Hemedivafa F., koushkbaghy M. 2001, Inducing cell- mediated immunity in BALB/C mice using liposomes encapsulated with crude Leishmania antigens (CLA) (WORLDleish 2, MAY 20-24, 2001, Crete, Greece) (Poster Presentation).

7) Jaafari M.R., Sadri K., Arefee A., Amani M., Mahboudi F. Protection of BALB/c mice against cutaneous leishmaniasis by immunization with recombinant leishmania major surface glycoprotein (rGP63)/ liposomes (Pharmacy and Pharmaceutical Sciences World Congress, Nice, France, Sept. 2002) (Poster Presentation).

8) M. Tabbakhian, S. Daneshamouz, M. R. Jaafari, N. Tavakoli, Preparation and Characterization of niosomes containing finasteride (AAPS American Association of pharmaceutical Sciences annual meeting and expositon Toronto, Canada Nov. 10-15, 2003) (Poster Presentation).

9) M. R. Jaafari, A. Arefee, K. Sadri, M. Amani and F. Mohboudi, Vaccination of BALB/c mice against cutaneous leishmaniasis using fusogenic liposomes incorporated with recombinant major surface glycoprotein of leishmania (rGP63), Journal of Pharmacy and Pharmacology, 55: S-69 (2003), (British Pharmaceutical Conference, Harrogate, UK, Sept. 15-17, 2003) (Poster Presentation).

10) M. R. Jaafari, A. Ghafarian, A. Farrokh-Gisour, M. Amani and F. Mahboudi, 2003,Vaccination of BALB/c mice against cutaneous leishmaniasis using neutral liposomes incorporated with recombinant major surface glycoprotein of of leishmania (rGP63). Sixth Int. Conference, Liposome Advances: Progress in drug and vaccine delivery, School of Pharmacy, University of London, Dec. 15-19, 2003, London, UK, Abstract book: page 97(Poster Presentation).

11) Y. Sohrabi, M. R. Jaafari, A., A. Miramin Mohammadi and A. Khamesipour, Induction of cell mediated immunity against leishmaniasis using mannan coated liposomes containing autoclaved leishmania major. Sixth Int. Conference, Liposome Advances: Progress in drug and vaccine delivery, School of Pharmacy, University of London, Dec. 15-19, 2003, London, UK, Abstract book: page 128 (Poster Presentation).

12) A. Khamesipour, M. R. Jaafari, A., A. Miramin Mohammadi and Y. Sohrabi, 2003,Vaccination of BALB/c mice with liposomes/autoclaved leishmania major composed of different phospholipids. Sixth Int. Conference, Liposome Advances: Progress in drug and vaccine delivery, School of Pharmacy, University of London, Dec. 15-19, 2003, London, UK, Abstract book: page 108 (Poster Presentation).

13) M. R. Jaafari, A. Ghafarian, A. Farrokh-Gisour, M. Amani and F. Mahboudi, Vaccination of BALB/c mice against cutaneous leishmaniasis using mannan coated positively charged liposomes incorporated with recombinant major surface glycoprotein of leishmania (rGP63). 9th Liposome Research Days, Above and Beyond, May 11-15, 2004, Hsinchu, Taiwan, Abstract book: page 110 (Poster Presentation).

14) Tafaghodi M., Sajadi S.A., Jaafari M.R., Zakavi S.R., Momen-Nejad M. Gamma-scintigraphic evaluation of the clearance characteristics of microspheres in the human nose, 2nd Pharmaceutical Sciences World Congress, The Global Translational of science into Drug Development in Advancing Therapy, May 30-June 3, 2004, Kyoto, Japan, Abstract book: page 253 (Poster Presentation).

15) Sajadi Tabassi S.A., Tafaghodi M., Jaafari M.R., Dextran microspheres as a potential delivery systems for nasa immunization- in vitro and in vivo characterization, Proc. International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Nuremberg, 15-18 March 2004., page 501-502(Poster Presentation).

16) Jaafari, M.R. Badiee A. Samiei A., Soroush D., Khamesipour A., Amani M., Mahboudi F., Vaccination of BALB/c Mice against cutaneous leishmaniais (CL) using lipsomes containing recombinant major surface glycoprotein of leishmania (rGP63) and CPG ODNs, WORLDleish 3, April 10-15, 2005, Terrasini, Palermo, Italy Abstract book: page: 257(Oral Presentation).

17) Sohrabi Y., Jaafari M.R., Miramin Mohammadi A., Eskandari S.E., Khamesipour A., Evaluation of immune response against leishmaniasis induced by liposomes containing freeze/thawed thimrosal treated L. major (KLM) in C57BL/6 MICE, WORLDleish 3, April 10-15, 2005, Terrasini, Palermo, Italy Abstract book: page: 279(Poster Presentation).

18) Badiee A., Jaafari M.R., Samiei A., Soroush D., Webb J., Khamesipour A., Immunization of BALB/c mice against cutaneous leishmaniasis (CL) using lipsomes containing rLmSTI1 and CPG ODNs, WORLDleish 3, April 10-15, 2005, Terrasini, Palermo, Italy Abstract book: page: 238(Poster Presentation).

19) Sohrabi Y.,Jaafari M.R., Miramin Mohammadi A., Eskandari S.E., Khamesipour A., 2005, Evaluation of immune response against leishmaniasis in resistance C57BL/6 mice immunized with liposomes containing autoclaved leishmania major with BCG. Cell. Mol. Biol. Lett., 10 (Supp.): 98 (Poster Presentation).

20) Ramezani M., Emamy J.A.,Jaafari M.R., Behravan M., Evaluation of leishmaniacidal effect of Euphorbia bunjei extract by in vitro leishmaniacidal assay using promastigotes of L. major, AHAT BSAS International Conference, Nov. 14-18, 2005, Khon Kaen, Thailand, P20-21 (Poster Presentation).

21) Sajadi Tabassi S.A., Tafaghodi M.,Jaafari M.R. Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid, 9th Commonwealth Pharmaceutical Association Conference, 1-5 August 2007, Kuala Lumpur, Malaysia, Abstract book, P 116 (Poster Presentation).

22) Mahmoud R Jaafari, Zhaohua Huang, Francis C Szoka, New lipids for liposome construction and use in the treatment of cancer. International Liposome Society 2007 Annual Meeting, Liposome Advances: Progress in Drug and Vaccine Delivery, School of Pharmacy, University of London, Dec. 8-11, 2007, London, UK, Abstract book: page 28 (Oral Presentation)

23) M. R. Jaafari, A. Badiee, A. Khamesipour, A. Samiei, M. Tavassoti Kheiri, F. Barkhordari, and F. Mohboudi, Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of leishmania (rGP63): The role of bilayer composition, International Liposome Society 2007 Annual Meeting, Liposome Advances: Progress in Drug and Vaccine Delivery, School of Pharmacy, University of London, Dec. 8-11, 2007, London, UK, Abstract book: page 65 (Poster Presentation).

24) Zhaohua Huang, Mahmoud R Jaafari, Francis C Szoka, Evaluation of nanolipid formulations as drug carriers, 9th US-Japan Symposium on Drug Delivery Systems, The Westin Maui, Lahaina, Maui, Hawaii, December 16-20, 2007 (Oral Presentation).

25) M. R. Jaafari, A. Khamesipour, A. Samiei, D. Soroush, M. Tavassoti Kheiri, F. Barkhordari, and F. Mohboudi, Vaccination of BALB/c mice against cutaneous leishmaniasis using LPD nanoparticles containing rLmaCIN prepared with CpG Oligodeoxynucleotides. 11th Liposome Research Days Conferences, Innovation from Liposome, July 19-22, 2008, Yokohama, Japan, Abstract Book: page 211(Poster Presentation).

26) M. R. Jaafari, A. Badiee, A. Khamesipour, A. Samiei, D. Soroush, M. Tavassoti Kheiri, F. Barkhordari, and F. Mohboudi, The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of leishmania (rGP63). 11th Liposome Research Days Conferences, Innovation from Liposome, July 19-22, 2008, Yokohama, Japan, Abstract Book: page 216 (Poster Presentation).

27) N. Bavarsad, M. R. Jaafari, S. Fazly Bazaz, M. M. Lotfi Heravi, S. Ghorbani, A. Samiei, D. Soroush, A. Khamesipour, Activity of topical liposomes containing paromomycin sulfate against experimental cutaneous leishmaniasis. 11th Liposome Research Days Conferences, Innovation from Liposome, July 19-22, 2008, Yokohama, Japan, Abstract Book: page 122 (Poster Presentation).

28) B. Malaekeh-Nikouei, M. R. Jaafari, S. A. Sajadi Tabassi, A. Samiei, The effect of phospholipid type and size on immunosuppressive activities of liposomes encapsulated with Cyclosporine A. 11th Liposome Research Days Conferences, Innovation from Liposome, July 19-22, 2008, Yokohama, Japan, Abstract Book: page 208 (Poster Presentation).

29) Maryam Iman, Zhaohua Huang, Francis C. Szoka, Jr. and Mahmoud R. Jaafari Colloidal, relative toxicity and in vivo antileishmanial properties of liposome-intercalated Amphotericin B prepared from distigmasterylhemisuccinoyl-glycero-phosphocholin, International Liposome Research Days and Lipids, Liposomes and Membrane Biophysics, Aug. 4-8, 2010, University of British Colombia, Vancouver, Canada (Poster Presentation).

30) Mohamadreza Amin, Ali Badiee, Mahmoud Reza Jaafari, Biodistribution of RGD-targeted liposomes containing doxorubicin in mice bearing C-26 colon Carcinoma, ESF-UB Conference in Biomedicine on Nanomedicine: Reality Now and Soon, 23-28 October 2010, Hotel Eden Roc, Sant Feliu de Guixols, Spain (Poster Presentation).
 
 
 
 
 
 
 

تاريخ بروز رساني : يكشنبه 18/02/90 ساعت 10:06

مشهد، میدان آزادی، پردیس دانشگاه فردوسی، دانشکده داروسازی صندوق پستی: 1365-91775 تلفن: 66-8823255 511 نمابر: 8823251 511 پست الکترونیک: phs.it@mums.ac.ir
تمام حقوق مادی و معنوی این سایت مربوط به دانشگاه علوم پزشکی مشهد می باشد و هرگونه کپی برداری از مطالب آن تنها با ذکر منبع بلامانع است .